Replies to post #59344 on Regen BioPharma Inc (RGBP)

[Mic ll]

On April 7, 2021 Oncology Pharma, Inc. reported that it had been granted an exclusive worldwide license by Regen BioPharma, Inc. to develop and commercialize pancreatic cancer treatments utilizing Regens proprietary intellectual property pertaining to mRNA